Showing results (2011-2020 of 2,148) with videos related to

Sort By:
Pageof 215
The New England Journal of Medicine|November 18, 2024
Left Atrial Appendage Closure after Ablation for Atrial FibrillationOussama M Wazni, Walid I Saliba, Devi G Nair, et al.
Scientific Reports|May 7, 2020
The polygenic architecture of left ventricular mass mirrors the clinical epidemiologyJonathan D Mosley, Rebecca T Levinson, Eric Farber-Eger, et al.
Blood Advances|May 8, 2020
Molecular mechanisms mediating relapse following ivosidenib monotherapy in IDH1-mutant relapsed or refractory AMLSung Choe, Hongfang Wang, Courtney D DiNardo, et al.
Clinical Pharmacology and Therapeutics|April 9, 2010
Integration of genetic, clinical, and INR data to refine warfarin dosingP Lenzini, M Wadelius, S Kimmel, et al.
Blood|June 8, 2017
Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemiaEytan M Stein, Courtney D DiNardo, Daniel A Pollyea, et al.
Blood Advances|May 4, 2023
Interaction between myelodysplasia-related gene mutations and ontogeny in acute myeloid leukemiaJoseph G W McCarter, David Nemirovsky, Christopher A Famulare, et al.
Nature|March 16, 2023
MEN1 mutations mediate clinical resistance to menin inhibitionFlorian Perner, Eytan M Stein, Daniela V Wenge, et al.
Transplantation and Cellular Therapy|May 25, 2021
Relapse after Allogeneic Stem Cell Transplantation of Acute Myelogenous Leukemia and Myelodysplastic Syndrome and the Importance of Second Cellular TherapyCorrado Zuanelli Brambilla, Stephanie M Lobaugh, Josel D Ruiz, et al.
Pageof 215